Keele Research Repository

Article

Khera, T, Hunt, LP, Davis, S, Gooberman-Hill, R, Thom, H, Xu, Y, Paskins, Z ORCID: https://orcid.org/0000-0002-7783-2986, Peters, TJ, Tobias, JH and Clark, EM (2022) A clinical tool to identify older women with back pain at high risk of osteoporotic vertebral fractures (Vfrac): a population-based cohort study with exploratory economic evaluation. Age and Ageing, 51 (3).

Rifkin-Zybutz, R, MacNeill, S, Davies, SJ, Dickens, C, Campbell, J, Anderson, IM, Chew-Graham, CA ORCID: https://orcid.org/0000-0002-9722-9981, Peters, TJ, Lewis, G, Wiles, N and Kessler, D (2020) Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial. Journal of Psychopharmacology, 34 (12). 1342 - 1349.

Khera, TK, Burston, A, Davis, S, Drew, S, Gooberman-Hill, R, Paskins, Z ORCID: https://orcid.org/0000-0002-7783-2986, Peters, TJ, Tobias, JH and Clark, EM (2019) An observational cohort study to produce and evaluate an improved tool to screen older women with back pain for osteoporotic vertebral fractures (Vfrac): Study protocol. Archives of Osteoporosis, 14 (1).

Kessler, D, Burns, A, Tallon, D, Lewis, G, MacNeill, S, Round, J, Hollingworth, W, Chew-Graham, CA, Anderson, I, Campbell, J, Dickens, C, Macleod, U, Gilbody, S, Davies, S, Peters, TJ and Wiles, N (2018) Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Health Technology Assessment, 22 (63). 1 - 136.

Kessler, DS, MacNeil, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, SHEPHERD, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR). BMJ, 363.

Kessler, DS, MacNeill, SJ, Tallon, D, Lewis, G, Peters, TJ, Hollingworth, W, Round, J, Burns, A, Chew-Graham, CA, Anderson, IM, Shepherd, T, Campbell, J, Dickens, CM, Carter, M, Jenkinson, C, Macleod, U, Gibson, H, Davies, S and Wiles, NJ (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ, 363. k4218 - ?.